Decriminalization Vs Legalization Vs Medicalization Of Psychedelics

In case you missed it, we are in the midst of a psychedelic renaissance. There is a growing body of scientific research that shows potential, a lot of media coverage is bringing quite a bit attention, and few states have passed legislation that allows for more access.

Many people believe that more people should have access to psychedelics. But “how” is the question.

In this article, we’ll review three possible models, and I will share some insights as well. I can’t even begin to cover all the complexities and its impact on different communities so I will give a broad overview. It is likely that nuances of these approaches will contribute to ongoing discussions about the role of psychedelics in healthcare and in our society.  

Decriminalization

Decriminalization refers to the reduction or elimination of criminal penalties associated with the possession or use of a particular substance, in this case, psychedelics. It doesn’t mean that the substance becomes legal, but rather that law enforcement focuses on treating possession as a civil offense or a low-level misdemeanor, often emphasizing diversion to treatment and education programs over incarceration. The goal is to shift the approach from punishment to harm reduction and public health.

An example would be the City of Oakland, where psychedelics are decriminalized, but there is no legal way to purchase them.

Legalization

Legalization involves the process of making a substance legal for use, sale, and possession, subject to certain regulations. In the context of psychedelics, legalization would mean that these substances are no longer prohibited, and individuals can engage in their use within a regulatory framework. Legalization is often associated with the establishment of specific guidelines and restrictions to ensure public safety, product quality, and responsible consumption.

Examples include tobacco, alcohol, or states with legalized cannabis. Another example is Oregon psilocybin service centers, where you can legally ingest psilocybin with a licensed facilitator in a licensed facility but no medical diagnosis or professional is required by state law.

Medicalization

Medicalization refers to the incorporation of a substance or a therapeutic practice into the domain of formal medical treatment. In the case of psychedelics, medicalization involves using these substances for therapeutic purposes under the supervision of healthcare professionals. This approach typically includes rigorous clinical research, standardized protocols, and regulatory approval to ensure the safety and efficacy of psychedelic-assisted therapies. Medicalization aims to leverage the therapeutic potential of psychedelics in treating mental health conditions.

An example would be the eventual FDA approval of MDMA that will likely require a diagnosis by a qualified health practitioner and a licensed psychotherapist.

Now that you are a legal expert in this topic and ready to fight in the comment sections, let’s look at the impacts of different models…

Impacts of the 3 Models

Access and Availability 

• Decriminalization aims to reduce legal consequences for possessing small amounts of psychedelics. While it may decrease the fear of legal repercussions, access remains limited to a non-commercial context, typically focusing on personal use.

• Legalization opens the door to regulated markets, making psychedelics more widely available. Individuals can purchase these substances from licensed vendors, and the market is subject to governmental oversight.

• Medicalization: Access to psychedelics is primarily through healthcare professionals in medicalized settings. Patients may need to meet specific criteria or have a diagnosed mental health condition to access psychedelic therapies.

Affordability

• Decriminalization: Affordability might be influenced by legal consequences, but the cost is not directly addressed. Users may still face financial barriers to access treatment or therapy. Loss of potential tax revenue could lead to less resources as well.

• Legalization: The cost can vary depending on the regulatory framework and taxation. There’s potential for profit-driven pricing, and affordability might be a concern for some individuals.

• Medicalization: Affordability is a potential challenge as psychedelic therapies may involve medical professionals and therapeutic settings. Insurance coverage is often uncertain, and out-of-pocket costs may be a barrier.

Safety and Quality Control

• Decriminalization: Quality control is not directly addressed, potentially leading to safety concerns as there are no regulations ensuring the purity of substances.

• Legalization: Legalization provides an opportunity for rigorous quality control measures, reducing the risks associated with contaminated or adulterated substances.

• Medicalization: Safety and quality control are prioritized in medical settings, with strict protocols in place to ensure the well-being of patients undergoing psychedelic therapies.

Cultural and Spiritual Considerations

• Decriminalization: Allows for personal and cultural use without legal consequences, acknowledging the cultural and spiritual significance of psychedelics.

• Legalization: The commercialization of psychedelics may clash with cultural or spiritual practices, potentially leading to concerns about the commodification of sacred substances.

• Medicalization: Focuses on the therapeutic and clinical aspects, potentially overlooking the cultural and spiritual dimensions of psychedelic use.

Research and Scientific Understanding

• Decriminalization: Doesn’t necessarily contribute directly to scientific research but may indirectly encourage open discussions and public awareness.

• Legalization: Can facilitate scientific research by providing legal frameworks for controlled studies, contributing to a better understanding of the effects and potential applications of psychedelics.

• Medicalization: Promotes rigorous scientific research to establish the efficacy and safety of psychedelic therapies, contributing to the integration of these treatments into mainstream healthcare.

Social Perception and Stigma

• Decriminalization: Aims to reduce stigma by treating drug use as a public health issue, potentially fostering more open conversations about psychedelics.

• Legalization: While reducing legal stigma, commercialization may introduce new societal stigmas, particularly if not well-regulated or if marketing strategies are perceived as exploitative.

• Medicalization: Shifts the perception toward psychedelics as legitimate therapeutic tools, potentially reducing stigma associated with their use for mental health treatment.

Conclusion

In this evolving discussion, recognizing the multifaceted impacts and engaging in informed conversations about the complexities is crucial. As psychedelics continue to carve their place in healthcare and culture, the balance between accessibility, safety, and cultural considerations will shape the trajectory of this psychedelic renaissance. What is the right approach? Only time will tell!